Search research articles
Contact Us
Filters
Showing results (61-70 of 134) with videos related to
Page
of 14
Sort By:
The Journal of Dermatology
|
May 13, 2014
Successful use of intravenous cyclophosphamide pulse therapy for interstitial lung disease in a patient with systemic sclerosis on hemodialysis
Takehiro Takahashi, Yoshihide Asano, Ryo Sunaga, et al.
The Journal of Dermatology
|
May 1, 2016
Linear scleroderma with prominent multiple lymphadenopathy followed by the development of polymyositis: A case report and review of published work
Takehiro Takahashi, Yoshihide Asano, Maiko Hirakawa, et al.
Experimental Dermatology
|
June 28, 2018
CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis
Takashi Taniguchi, Takuya Miyagawa, Satoshi Toyama, et al.
The Journal of Dermatology
|
February 16, 2016
Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis
Ryosuke Saigusa, Yoshihide Asano, Kouki Nakamura, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 8, 2014
HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models
Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, et al.
Modern Rheumatology
|
August 20, 2016
Plasma plasmin-α2-plasmin inhibitor complex levels may predict the effect of cyclophosphamide for systemic sclerosis-related interstitial lung disease
Ryosuke Saigusa, Yoshihide Asano, Kouki Nakamura, et al.
Nature Microbiology
|
March 13, 2019
Aedes aegypti AgBR1 antibodies modulate early Zika virus infection of mice
Ryuta Uraki, Andrew K Hastings, Alejandro Marin-Lopez, et al.
Clinical Pharmacology and Therapeutics
|
February 9, 2020
Higher Systemic Exposure to Unbound Active Metabolites of Regorafenib Is Associated With Short Progression-Free Survival in Colorectal Cancer Patients
Yutaro Kubota, Ken-Ichi Fujita, Takehiro Takahashi, et al.
The Journal of Investigative Dermatology
|
May 23, 2017
Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency
Ryosuke Saigusa, Yoshihide Asano, Kouki Nakamura, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2018
A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer
Hideaki Bando, Hideki Shimodaira, Kazumasa Fujitani, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 134) with videos related to
Sort By:
Page
of 14
The Journal of Dermatology
|
May 13, 2014
Successful use of intravenous cyclophosphamide pulse therapy for interstitial lung disease in a patient with systemic sclerosis on hemodialysis
Takehiro Takahashi, Yoshihide Asano, Ryo Sunaga, et al.
The Journal of Dermatology
|
May 1, 2016
Linear scleroderma with prominent multiple lymphadenopathy followed by the development of polymyositis: A case report and review of published work
Takehiro Takahashi, Yoshihide Asano, Maiko Hirakawa, et al.
Experimental Dermatology
|
June 28, 2018
CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis
Takashi Taniguchi, Takuya Miyagawa, Satoshi Toyama, et al.
The Journal of Dermatology
|
February 16, 2016
Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis
Ryosuke Saigusa, Yoshihide Asano, Kouki Nakamura, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 8, 2014
HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models
Seiji Okazaki, Takehiro Takahashi, Tomokatsu Iwamura, et al.
Modern Rheumatology
|
August 20, 2016
Plasma plasmin-α2-plasmin inhibitor complex levels may predict the effect of cyclophosphamide for systemic sclerosis-related interstitial lung disease
Ryosuke Saigusa, Yoshihide Asano, Kouki Nakamura, et al.
Nature Microbiology
|
March 13, 2019
Aedes aegypti AgBR1 antibodies modulate early Zika virus infection of mice
Ryuta Uraki, Andrew K Hastings, Alejandro Marin-Lopez, et al.
Clinical Pharmacology and Therapeutics
|
February 9, 2020
Higher Systemic Exposure to Unbound Active Metabolites of Regorafenib Is Associated With Short Progression-Free Survival in Colorectal Cancer Patients
Yutaro Kubota, Ken-Ichi Fujita, Takehiro Takahashi, et al.
The Journal of Investigative Dermatology
|
May 23, 2017
Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency
Ryosuke Saigusa, Yoshihide Asano, Kouki Nakamura, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2018
A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer
Hideaki Bando, Hideki Shimodaira, Kazumasa Fujitani, et al.
Page
of 14